Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
“This device will become many patients’ primary epinephrine device because it removes the hurdle to administering epinephrine earlier in the anaphylactic process.” — Haley Overstreet, MD, Aspire Allergy & Sinus
Allergy & Immunology March 12th 2026
Conexiant
A device that restricts blood flow and is worn around the neck, that has not been shown to provide any clinical benefit, is being sold to vulnerable populations—including children as young as 13.
Emergency Medicine December 2nd 2025
The responder rate, defined as the percentage of patients who improved by 2 stages (ie, from severe to mild adhesions, or from severe to no adhesions, or from moderate to no adhesions) was also significantly higher in the Womed Leaf group vs the control group.
Obstetrics & Gynecology October 24th 2025
Clinical Advisor
After implantation during a minimally invasive outpatient procedure, the SetPoint device is programmed to automatically administer therapy on a predetermined schedule for up to 10 years, simplifying care for people living with RA.
Nurse Practitioner (NP) August 28th 2025
The Sonu Band, now FDA-cleared for children 12+, showed a -2.74 mean TNSS improvement with no adverse events in a 2-week study.
Allergy & Immunology July 3rd 2025
Journal of the American College of Cardiology (JACC)
The LAA’s role as the predominant site for thrombus formation in AFib patients positions LAAO as a significant therapeutic approach for stroke prevention.
Cardiology January 28th 2025